Recent YSCC Discoveries

Seven Yale School of Medicine faculty receive Yale Faculty Innovation Awards.

Using single-cell transcriptomics and proteomics, Yale researchers have created a detailed cell atlas of brains affected by Parkinson’s disease.

Better pain medications, known as Nav1.8 inhibitors, could be the first new drugs in decades for chronic pain conditions that don’t respond to existing treatments.

The National Academy of Medicine (NAM) has announced the election of two Yale School of Medicine (YSM) faculty members as new NAM members. Erol Fikrig, MD, is Waldemar Von Zedtwitz Professor of Medicine (Infectious Diseases), professor of epidemiology (microbial diseases) and of microbial pathogenesis, and section chief for infectious disease in YSM’s Department of Internal Medicine. Haifan Lin, PhD, is Eugene Higgins Professor of Cell Biology; professor of genetics; of obstetrics, gynecology & reproductive sciences; and of dermatology; and director of the Yale Stem Cell Center. They are among 90 newly elected regular members of NAM, along with 10 international members.

A listing of recent publications by Yale Cancer Center researchers and clinicians in the first quarter of 2024

Research examining health conditions unique to women, more prevalent in women, or affecting women differently than men have been at the heart of Women’s Health Research at Yale since its founding in 1998.

Endometriosis is an incurable condition where tissue similar to the lining of the uterus grows outside of the uterus, leading to significant pain and complications including infertility.

After 12 years as Dr. Taylor's administrative assistant and 15 years at Yale, Robin Vollono has decided to retire. Hear from supervisors, a colleague, and Robin herself on takeaways, impact, and why we may not need to tear up just yet.

This past August, Kutluk Oktay, MD, PhD, at Yale New Haven Hospital, performed the first ovarian transplant in the New England region, giving a patient a chance to regain fertility.